tiprankstipranks
Trending News
More News >
Trinity Biotech Plc (TRIB)
NASDAQ:TRIB

Trinity Biotech (TRIB) Stock Statistics & Valuation Metrics

Compare
329 Followers

Total Valuation

Trinity Biotech has a market cap or net worth of $13.66M. The enterprise value is $107.72M.
Market Cap$13.66M
Enterprise Value$107.72M

Share Statistics

Trinity Biotech has 18,632,019 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,632,019
Owned by Insiders
Owned by Institutions

Financial Efficiency

Trinity Biotech’s return on equity (ROE) is 0.90 and return on invested capital (ROIC) is -29.18%.
Return on Equity (ROE)0.90
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-29.18%
Return on Capital Employed (ROCE)-0.30
Revenue Per Employee161.99K
Profits Per Employee-83.66K
Employee Count380
Asset Turnover0.60
Inventory Turnover2.07

Valuation Ratios

The current PE Ratio of Trinity Biotech is -0.50. Trinity Biotech’s PEG ratio is 0.01.
PE Ratio-0.50
PS Ratio0.00
PB Ratio-0.26
Price to Fair Value-0.45
Price to FCF-0.75
Price to Operating Cash Flow-1.49
PEG Ratio0.01

Income Statement

In the last 12 months, Trinity Biotech had revenue of 61.55M and earned -31.79M in profits. Earnings per share was -1.80.
Revenue61.55M
Gross Profit21.44M
Operating Income-21.16M
Pretax Income-30.73M
Net Income-31.79M
EBITDA-16.91M
Earnings Per Share (EPS)-1.80

Cash Flow

In the last 12 months, operating cash flow was -6.20M and capital expenditures -10.06M, giving a free cash flow of -16.26M billion.
Operating Cash Flow-6.20M
Free Cash Flow-16.26M
Free Cash Flow per Share-0.87

Dividends & Yields

Trinity Biotech pays an annual dividend of $1.1, resulting in a dividend yield of ―
Dividend Per Share$1.1
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.47
52-Week Price Change-73.96%
50-Day Moving Average0.71
200-Day Moving Average0.94
Relative Strength Index (RSI)58.03
Average Volume (3m)1.61M

Important Dates

Trinity Biotech upcoming earnings date is Sep 2, 2025, TBA (Confirmed).
Last Earnings DateMay 21, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend DateJun 05, 2015

Financial Position

Trinity Biotech as a current ratio of 1.28, with Debt / Equity ratio of -286.42%
Current Ratio1.28
Quick Ratio0.68
Debt to Market Cap5.57
Net Debt to EBITDA-5.65
Interest Coverage Ratio-1.77

Taxes

In the past 12 months, Trinity Biotech has paid 486.00K in taxes.
Income Tax486.00K
Effective Tax Rate-0.02

Enterprise Valuation

Trinity Biotech EV to EBITDA ratio is -24.36, with an EV/FCF ratio of -28.89.
EV to Sales6.69
EV to EBITDA-24.36
EV to Free Cash Flow-28.89
EV to Operating Cash Flow-98.25

Balance Sheet

Trinity Biotech has $5.17M in cash and marketable securities with $100.76M in debt, giving a net cash position of $95.60M billion.
Cash & Marketable Securities$5.17M
Total Debt$100.76M
Net Cash$95.60M
Net Cash Per Share$5.13
Tangible Book Value Per Share-$0.24

Margins

Gross margin is 33.98%, with operating margin of -34.38%, and net profit margin of -51.64%.
Gross Margin33.98%
Operating Margin-34.38%
Pretax Margin-49.92%
Net Profit Margin-51.64%
EBITDA Margin-27.46%
EBIT Margin-30.49%

Analyst Forecast

The average price target for Trinity Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast8.31%
EPS Growth Forecast9.98%

Scores

Smart ScoreN/A
AI Score49
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis